Chloroprocaine Hci Injection, Solution
Product Images NDC 51662-1408

13 FDA label images from Hf Acquisition Co Llc, Dba Healthfirst · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Chloroprocaine Hci (NDC 51662-1408). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of Chloroprocaine HCl, showing a benzene ring with an amino group (NH2) and chlorine (Cl) substituents, along with an ester functional group linked to a diethylaminoethyl side chain and a hydrochloride (HCl) moiety.*
FDA Label Image

Description (Description 1)

Description (Description 1)
A data table presenting the formula composition (mg/mL) of various Nesacaine injection products. Columns include concentrations of Chloroprocaine HCl, Sodium Chloride, Disodium EDTA dihydrate, and Methylparaben across Nesacaine 1%, 2%, Nesacaine-MPF 2%, and Nesacaine-MPF 3% formulations.*
FDA Label Image

Precautions (Precautions)

Precautions (Precautions)
A table listing drug classes and examples of drugs within each class. Classes include Nitrates/Nitrites, Local anesthetics, Antineoplastic agents, Antibiotics, Antimalarials, Anticonvulsants, and Other drugs. Each class is followed by multiple example drug names.*
FDA Label Image

Dosage (Dosage)

Dosage (Dosage)
A data table showing anesthetic procedures using Chloroprocaine HCl injection solution. It lists procedures such as Mandibular, Infraorbital, Brachial plexus, Digital (without epinephrine), Pudendal, and Paracervical, with corresponding solution concentration percentages, volume ranges in milliliters, and total dose ranges in milligrams.*
FDA Label Image
FDA Label Image

Vial 1 (Vial 1)

Vial 1 (Vial 1)
A close-up of a brown glass vial with a teal plastic cap and aluminum seal. The label on the vial identifies it as Nesacaine MPF (chloroprocaine HCl Injection, USP) 2% solution, 20 mg/mL concentration, in a 20 mL single dose vial. The label mentions it is methylparaben free and EDTA free, for infiltration, nerve block, caudal, and epidural anesthesia, not for spinal anesthesia. Rx only.*
FDA Label Image

Vial 2 (Vial 2)

Vial 2 (Vial 2)
A close-up image of an amber glass vial with a teal plastic flip-off cap, containing Chloroprocaine HCl injection solution. The label includes storage instructions such as protecting from light, storing at 20° to 25°C, and discarding if the solution is discolored. The vial is labeled by Fresenius Kabi USA, LLC, Lake Zurich, IL.*
FDA Label Image

Vial 3 (Vial 3)

Vial 3 (Vial 3)
The image shows the top portion of a brown glass vial with a teal flip-off plastic cap and sealed with a silver aluminum band. The vial includes a white label featuring text with lot and expiration date details, part of the packaging for Chloroprocaine HCl injection. The vial is from HF Acquisition Co LLC, DBA HealthFirst.*
FDA Label Image

Serialized Vial (Serialized Vial Labeling)

Serialized Vial (Serialized Vial Labeling)
Nesacaine MPF (chloroprocaine HCl) Injection USP 2% solution in a 20 mL amber glass single-dose vial with a teal cap. The label indicates a 400 mg/20 mL (20 mg/mL) strength and notes usage for infiltration, nerve block, caudal, and epidural anesthesia. The product is methylparaben-free and EDTA-free, distributed by HF Acquisition Co LLC.*
FDA Label Image

Pouch Labeling (51662 1408 2 Pouch)

Pouch Labeling (51662 1408 2 Pouch)
Label for NESACAINE-MPF Chloroprocaine HCl injection, USP 2% (20 mg/mL) in a 20 mL vial. The label includes the NDC 51662-1408-2, lot number, expiration date, storage instructions, and manufacturer HF Acquisition Co LLC, Mukilteo, WA. The label specifies use for infiltration, nerve block, caudal and epidural anesthesia, and notes the product is methylparaben and EDTA free.*
FDA Label Image

Vial Label (51662 1408 2 Vial)

Vial Label (51662 1408 2 Vial)
Label for Nesacaine-MPF (chloroprocaine HCl injection) 2% solution, providing 400 mg per 20 mL (20 mg/mL). It is for infiltration, nerve block, caudal, and epidural anesthesia but not for spinal anesthesia. The label notes methylparaben and EDTA free, single dose vial of 20 mL, from Fresenius Kabi, Lake Zurich, IL.*
FDA Label Image

Case Labeling (51662 1408 3 Case)

Case Labeling (51662 1408 3  Case)
Label for NESACAINE-MPF (CHLOROPROCAINE HCI Injection, USP) 2% (400 mg/20 mL) 20 mg/mL, 20 mL vial, case of 25. The label includes the NDC 51662-1408-3, lot number, expiration date, and manufacturer HF Acquisition Co LLC, Mukilteo, WA. The label specifies the drug is for infiltration, nerve block, caudal and epidural anesthesia, and indicates it is sterile, nonpyrogenic, methylparaben-free, and EDTA-free.*
FDA Label Image

Rfid Label (51662 1408 3 Rfid)

Rfid Label (51662 1408 3 Rfid)
Label from a pharmaceutical product containing Chloroprocaine HCl injection, solution. The label shows text indicating serialized identifiers including GTIN and lot number, with instructions to see the manufacturer's insert. Distributed by HF Acquisitions Co., LLC in Mukilteo, WA 98275. The label includes a QR code on the right side and is affixed on a white background.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.